Epstein-Barr Virus IgM
- UID
- IMP/IVD/2020/001078_c6efcd5df779806c89b4472d6632359e_0841c6220ea3e211eb924d90c2a80057
- Device class
- Class B
- Brand name
- NovaLisa®
- License holder
- OSB Agencies Private Limiated
- Approving authority
- CDSCO
- Product information
- The Epstein-Barr Virus (NovaLisa®) IgM ELISA is intended for the qualitative determination of IgM class antibodies against Epstein-Barr Virus viral capsid antigen (NovaLisa®) in human serum or plasma (NovaLisa®)
Epstein-Barr Virus IgM is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001078_c6efcd5df779806c89b4472d6632359e_0841c6220ea3e211eb924d90c2a80057. This device is marketed under the brand name NovaLisa®. The license holder is OSB Agencies Private Limiated, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.